Sarah Keller

Sarah Keller

Auto-generated profile, based on publicly available information

Sarah Keller

Department of Chemistry, University of Basel, CH-4058 Basel, Switzerland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2021 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
YLYan Lin
Yan Lin
HBHarley Betts
Harley Betts
SKSarah Keller
Sarah Keller
Kevin CariouKevin Cariou
Kevin Cariou
Gilles GasserGilles Gasser
Gilles Gasser
This review provides insight into the rapidly expanding field of metal-based antifungal agents.

30 July 2018 in Journal of Materials Chemistry C
Verified
Journal Article
Closed access
PDF file
MAMurat Alkan-Zambada
Murat Alkan-Zambada
SKSarah Keller
Sarah Keller
LMLaura Martínez-Sarti
Laura Martínez-Sarti
APAlessandro Prescimone
Alessandro Prescimone
JJJosé M. Junquera-Hernández
José M. Junquera-Hernández
Catherine HousecroftCatherine Housecroft
Catherine Housecroft
Bright and stable LECs with [Cu(P^P)(N^N)][PF6] complexes containing 6-alkoxy- or 6-phenyloxy-2,2′-bipyridine ligands.

16 June 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
SKSarah Keller
Sarah Keller
APAlessandro Prescimone
Alessandro Prescimone
MPMaria-Grazia La Placa
Maria-Grazia La Placa
JJJosé M. Junquera-Hernández
José M. Junquera-Hernández
HBHenk J. Bolink
Henk J. Bolink
Catherine HousecroftCatherine Housecroft
Catherine Housecroft
Heteroleptic [Cu(P^P)(N^N)][PF6] complexes, where N^N is 5,5′-dimethyl-2,2′-bipyridine (5,5′-Me2bpy), 4,5,6-trimethyl-2,2′-bipyridine (4,5,6-Me3bpy), 6-(tert-butyl)-2,2′-bipyridine (6-tBubpy) and 2-ethyl-1,10-phenanthroline (2-Etphen) and P^P is either bis(2-(diphenylphosphino)phenyl)ether (POP, PIN [oxydi(2,1-phenylene)]bis(diphenylphosphane)) or 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (xantphos, PIN (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane)) have been synthesized and their NMR spectroscopic, mass spectrometric, structural, electrochemical and photophysical properties were investigated. The single-crystal structures of [Cu(POP)(5,5′-Me2bpy)][PF6], [Cu(xantphos)(5,5′-Me2bpy)][PF6], [Cu(POP)(6-tBubpy)][PF6], [Cu(POP)(4,5,6-Me3bpy)][PF6]·1.5Et2O, [Cu(xantphos)(4,5,6-Me3bpy)][PF6]·2.33CH2Cl2, [Cu(POP)(2-Etphen)][PF6] and [Cu(xantphos)(2-Etphen)][PF6] are described. While alkyl substituents in general exhibit electron-donating properties, variation in the nature and substitution-position of the alkyl group in the N^N chelate leads to different effects in the photophysical properties of the [Cu(P^P)(N^N)][PF6] complexes. In the solid state, the complexes are yellow to green emitters with emission maxima between 518 and 602 nm, and photoluminescence quantum yields (PLQYs) ranging from 1.1 to 58.8%. All complexes show thermally activated delayed fluorescence (TADF). The complexes were employed in the active layer of light-emitting electrochemical cells (LECs). The device performance properties are among the best reported for copper-based LECs, with maximum luminance values of up to 462 cd m−2 and device half-lifetimes of up to 98 hours.

19 February 2018 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
SKSarah Keller
Sarah Keller
APAlessandro Prescimone
Alessandro Prescimone
Edwin Charles ConstableEdwin Charles Constable
Edwin Charles Constable
Catherine HousecroftCatherine Housecroft
Catherine Housecroft
The heteroleptic complexes [Cu(tBu-xantphos)(bpy)][PF6] and [Ag(tBu-xantphos)(bpy)][PF6], where tBu-xantphos = 9,9-dimethyl-4,5-bis(di-tert-butylphosphino)xanthene and bpy = 2,2′-bipyridine have been synthesized and their photophysical properties investigated. Single crystal X-ray diffraction studies of the compounds under ambient and increased pressure are presented; increase in pressure results in little structural perturbation. For the copper(I) complexes, the effects of changing the N^N ligand from bpy to 6-methyl-2,2′-bipyridine (6-Mebpy), 6-bromo-2,2′-bipyridine (6-Brbpy), and 4,4′-di(tert-butyl)-2,2′-bipyridine (4,4′-tBu2bpy) were also investigated. Emissions from the copper(I) complexes are weak, both in solution and the solid state and this is attributed to vibrational quenching effects of the tert-butyl substituents of the tBu-xantphos ligands.

19 November 2019 in Advanced Therapeutics
Verified
Journal Article
Open access
PDF file
PFPatrick S. Felder
Patrick S. Felder
SKSarah Keller
Sarah Keller
Gilles GasserGilles Gasser
Gilles Gasser
After the first successful clinical trials of monometallic photosensitizers (PSs) for photodynamic therapy (PDT), the use of polynuclear complexes is currently coming to the fore. These increasingly complex systems bear a high potential to overcome the drawbacks of their mononucleic peers by, for example, increasing the solubility of the PDT PSs and therefore their pharmacokinetic behavior, changing their internal quantum, and singlet oxygen efficiencies or adding supplementary imaging or therapeutical modalities, thus opening up the field for approaches in personalized medicine by combining therapy and diagnosis together in a single treatment. In this review, the most promising examples of polymetallic complexes used as PSs for anticancer PDT are presented.

27 April 2020 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
YLYan Lin
Yan Lin
YOYih Ching Ong
Yih Ching Ong
SKSarah Keller
Sarah Keller
JKJohannes Karges
Johannes Karges
RBRafika Bouchene
Rafika Bouchene
Gilles GasserGilles Gasser
Gilles Gasser
Helminthiases, a group of neglected tropical diseases, affect more than one billion people mainly in tropical and subtropical regions. Moreover, major intestinal protozoa have a significant impact on global public health. Albendazole (ABZ) is a broad-spectrum anthelmintic recommended by the World Health Organisation (WHO). However, drug resistance is emerging due to its widespread use. In order to tackle this problem, taking into account the spectacular results obtained with ferroquine, an organometallic derivatization of the antimalarial drug chloroquine, we have prepared, in this study, a series of new ferrocenyl and ruthenocenyl derivatives of the organic drug ABZ and assessed their activity against different helminths and protozoans, namely Trichuris muris, Heligmosomoides polygygrus, Schistosoma mansoni, Giardia lamblia, Haemonchus contortus and Toxoplasma gondii. The ferrocene-containing ABZ analogue 2d exhibited over 70% activity against T. muris adults in vitro at 200 μM and no toxicity to mammalian cells (IC50 >100 μM). H. polygyrus adults were not affected by any of the derivatives tested. Against T. gondii, the ferrocene-containing ABZ analogues 1a and 2d showed better in vitro activity than ABZ and low toxicity to the host cells. The activity of the analogous ruthenocenyl compound 2b against S. mansoni and T. gondii in vitro might be attributed to its toxicity towards the host cells rather than a specific antiparasitic activity. These results demonstrate that the derivatives show a species specific in vitro activity and the choice of the organometallic moieties attached to the organic drug is playing a very important role. Two of our organometallic compounds, namely 1b and 2d, were tested in T. muris infected mice. At a 400 mg kg−1 dose, the compounds showed moderate worm burden reductions but low worm expulsion rates. Overall, this work, which is one of the first studies reporting the potential of organometallic compounds on a very broad range of parasitic helminths and protozoan, is a clear confirmation of the potential of organometallic complexes against parasites of medical and veterinary importance.